Correlation Between Kymera Therapeutics and Arvinas
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Arvinas, you can compare the effects of market volatilities on Kymera Therapeutics and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Arvinas.
Diversification Opportunities for Kymera Therapeutics and Arvinas
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kymera and Arvinas is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Arvinas go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Arvinas
Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.03 times more return on investment than Arvinas. However, Kymera Therapeutics is 1.03 times more volatile than Arvinas. It trades about 0.05 of its potential returns per unit of risk. Arvinas is currently generating about 0.0 per unit of risk. If you would invest 2,752 in Kymera Therapeutics on August 28, 2024 and sell it today you would earn a total of 1,846 from holding Kymera Therapeutics or generate 67.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kymera Therapeutics vs. Arvinas
Performance |
| Timeline |
| Kymera Therapeutics |
| Arvinas |
Kymera Therapeutics and Arvinas Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Arvinas
The main advantage of trading using opposite Kymera Therapeutics and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |